March 11 (Reuters) - A federal judge has ruled in favor of Merck MRK.N in litigation accusing the drugmaker of concealing the risks of Gardasin, a vaccine to prevent cervical and other fatal cancers.
The decision was made public on Tuesday by U.S. District Judge Kenneth Bell in Charlotte, North Carolina.
(Reporting by Jonathan Stempel in New York)
((jon.stempel@thomsonreuters.com; +1 646 223 6317; Reuters Messaging: jon.stempel.thomsonreuters.com@reuters.net))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.